Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Pelthos Therapeutics Inc. (PTHS) ownership amendment reports that 3i, LP beneficially owns 383,447 shares, or 9.99% of the common stock. 3i Management LLC and its manager, Maier Joshua Tarlow, may each be deemed to beneficially own the same shares; each reports shared voting and dispositive power over them.
The reported amount comprises 373,605 shares held by 3i and 9,842 shares issuable upon conversion of its senior secured convertible note. Conversion is subject to a 9.99% blocker that bars conversion if it would result in 3i and specified related persons owning more than that percentage immediately after conversion. Pelthos had 3,828,469 shares outstanding as of August 10, 2026.
Key Figures
Beneficially owned shares:383,447 sharesOwnership percentage:9.99%Shares held directly:373,605 shares+3 more
6 metrics
Beneficially owned shares383,447 sharesReported by 3i, LP; 3i Management LLC and Maier Joshua Tarlow may each be deemed to beneficially own the same shares.
Ownership percentage9.99%Reported beneficial ownership percentage for each reporting person.
Shares held directly373,605 sharesCommon stock held directly by 3i, LP.
Shares issuable upon conversion9,842 sharesShares issuable upon conversion of 3i's note, subject to the beneficial ownership blocker.
Common shares outstanding3,828,469 sharesPelthos common stock outstanding as of August 10, 2026.
Original note principal$1,000,000Original principal amount of 3i's senior secured convertible note.
"conversion is subject to a 9.99% beneficial ownership blocker"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
senior secured convertible notefinancial
"the Note, which has an original principal amount of $1,000,000"
A senior secured convertible note is a loan a company takes that is backed by specific assets and has first claim on repayment ahead of other creditors, but can also be exchanged for company shares under agreed conditions. For investors it signals higher priority if the company struggles (like a mortgage holder vs a general creditor) while also creating potential stock dilution if the loan is converted into equity, affecting value and recovery prospects.
Rule 13d-3regulatory
"By reason of the provisions of Rule 13d-3"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many PTHS shares does 3i report beneficially owning?
3i, LP reports beneficial ownership of 383,447 shares, or 9.99% of Pelthos common stock. The reported ownership includes 373,605 shares held directly by 3i and 9,842 shares issuable upon conversion of its note. 3i Management LLC and Maier Joshua Tarlow may each be deemed to beneficially own the same shares.
What limits conversion of 3i's PTHS note?
A 9.99% beneficial ownership blocker bars conversion if 3i, together with its affiliates and specified persons acting as a group, would beneficially own more than 9.99% of Pelthos common stock issued and outstanding immediately after conversion.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Pelthos Therapeutics Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
171126204
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
171126204
1
Names of Reporting Persons
3i, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
383,447.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
383,447.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
383,447.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 3 to Statement on Schedule 13G (this ''Amendment No. 3''), such percentage is based on 3,828,469 shares of common stock, par value $0.0001 per share, of the issuer (the ''Common Stock'') outstanding as of August 10, 2026, as disclosed in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed by the issuer with the U.S. Securities and Exchange Commission (''SEC'') on August 13, 2026 (the ''Form 10-Q''). Beneficial ownership consists of 373,605 shares of Common Stock directly held by the reporting person and 9,842 shares of Common Stock issuable upon conversion of a senior secured convertible note (the ''Note'') held directly by the reporting person, which conversion is subject to a 9.99% beneficial ownership blocker (the ''Blocker'').
SCHEDULE 13G
CUSIP Number(s):
171126204
1
Names of Reporting Persons
3i Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
383,447.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
383,447.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
383,447.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 3, such percentage is based on 3,828,469 shares of Common Stock outstanding as of August 10, 2026, as disclosed in the Form 10-Q. Beneficial ownership consists of 373,605 shares of Common Stock indirectly held by the reporting person and 9,842 shares of Common Stock issuable upon conversion of the Note held indirectly by the reporting person, which conversion is subject to the Blocker.
SCHEDULE 13G
CUSIP Number(s):
171126204
1
Names of Reporting Persons
Maier Joshua Tarlow
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
383,447.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
383,447.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
383,447.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 3, such percentage is based on 3,828,469 shares of Common Stock outstanding as of August 10, 2026, as disclosed in the Form 10-Q. Beneficial ownership consists of 373,605 shares of Common Stock indirectly held by the reporting person and 9,842 shares of Common Stock issuable upon conversion of the Note held indirectly by the reporting person, which conversion is subject to the Blocker.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Pelthos Therapeutics Inc.
(b)
Address of issuer's principal executive offices:
4400 Route 9 South, Suite 1000, Freehold, New Jersey 07728
Item 2.
(a)
Name of person filing:
(i) 3i, LP, a Delaware limited partnership ("3i"); (ii) 3i Management LLC, a Delaware limited liability company ("3i Management''); and (iii) Maier Joshua Tarlow ("Mr. Tarlow"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to the Statement on Schedule 13G filed by the Reporting Persons with the SEC on July 8, 2025 (the "Schedule 13G"), pursuant to which the Reporting Persons have agreed to file this Amendment No. 3 and all subsequent amendments to this Amendment No. 3, the Schedule 13G, Amendment No. 1 to Schedule 13G filed by the Reporting Persons with the SEC on February 5, 2026 ("Amendment No. 1"), and Amendment No. 2 to Schedule 13G filed by the Reporting Persons with the SEC on May 7, 2026 ("Amendment No. 2" and, together with Amendment No. 1, the "Amendments") jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Amendment No. 3 should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of the Reporting Persons is 2 Wooster Street, 2nd Floor, New York, NY 10013.
(c)
Citizenship:
3i is a Delaware limited partnership. 3i Management is a Delaware limited liability company. Mr. Tarlow is a citizen of the United States.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
171126204
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The purpose of this Amendment No. 3 is to amend and supplement the Schedule 13G, and the Amendments, in order to update the beneficial ownership information on the cover pages and in Item 4 in the Schedule 13G and the Amendments. The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Amendment No. 3 and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on 3,828,469 shares of Common Stock outstanding as of August 10, 2026, as disclosed in the Form 10-Q. 3i holds (i) 373,605 shares of Common Stock and (ii) the Note, which has an original principal amount of $1,000,000, conversions of which are subject to the Blocker. 3i may convert the Note into an aggregate of 9,842 shares of Common Stock, as a result of the triggering of the Blocker, which prohibits 3i from converting the Note into shares of Common Stock if, as a result of such conversion, 3i, together with its affiliates and any persons acting as a group together with 3i or any of such affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock then issued and outstanding immediately after giving effect to such conversion. Consequently, 3i beneficially owns 383,447 shares of Common Stock (the "Shares"). 3i has the power to dispose of and the power to vote the Shares, which power may be exercised by 3i Management, the general partner of 3i. Mr. Tarlow, as the manager of 3i Management, has shared power to vote and/or dispose of the Shares. Mr. Tarlow does not directly own the Shares. By reason of the provisions of Rule 13d-3 of the Act, each of 3i Management and Mr. Tarlow may be deemed to beneficially own the Shares.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit 1 filed with the Schedule 13G.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
3i, LP
Signature:
/s/ Maier Joshua Tarlow
Name/Title:
Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP
Date:
11/12/2026
3i Management LLC
Signature:
/s/ Maier Joshua Tarlow
Name/Title:
Maier Joshua Tarlow, Manager
Date:
11/12/2026
Maier Joshua Tarlow
Signature:
/s/ Maier Joshua Tarlow
Name/Title:
Maier Joshua Tarlow
Date:
11/12/2026
Exhibit Information
LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated July 8, 2025 (incorporated by reference to Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on July 8, 2025)